FundedIQ
Biotechnology

Thunder Biotech: Funding, Investors & Team (Sep 2026)

Thunder Biotech is the operator of a biotechnology company intended to treat cancer. The company employs technology to treat cancer by empowering patients' immune systems to combat and eradicate the disease by modifying a patient's own immune cells (called macrophages) to have receptors that target cancer cells. Thunder Biotech was established in 2016 by Tod Schulthess in Alpine, Utah.

www.thunderbiotech.com LinkedIn Provo, United States 11-50 employees
Biotechnology Chemical Pharmaceutical B2B
Total raised
$19.4M
Rounds
3
Latest
Undisclosed round
Feb 2024

Thunder Biotech has raised $19.4M across 3 funding rounds on record, the most recent an undisclosed round of $100k announced in Feb 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Thunder Biotech Company Profile and Key Stats

Total funding raised
$19.4M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$100k in Feb 2024
Employees
11-50
reported band
Headquarters
Provo, United States

Latest funding round on record: Feb 2024.

Thunder Biotech Funding Rounds

Date
Round
Amount
Undisclosed round
$100k
Debt Financing
$1.0M
Undisclosed round
$18.3M

Thunder Biotech raised $18.3M in an undisclosed round announced in Aug 2022.

2 months later, a Debt Financing of $1.0M was announced in Oct 2022.

1.3 years later, an undisclosed round of $100k was announced in Feb 2024.

Thunder Biotech Founders and Leadership Team

Name
Role
Contact
Jeff Hone
Founder
Locked
Tod Schulthess
CEO

Contact details for the Thunder Biotech team: 1 of 2 have an email address on file.

Start 14-day free trial →

Thunder Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Thunder Biotech's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Thunder Biotech in Biotechnology and Provo

Companies Similar to Thunder Biotech

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Thunder Biotech Funding FAQs

What does Thunder Biotech do?

Thunder Biotech is the operator of a biotechnology company intended to treat cancer. The company employs technology to treat cancer by empowering patients' immune systems to combat and eradicate the disease by modifying a patient's own immune cells (called macrophages) to have receptors that target cancer cells. Thunder Biotech was established in 2016 by Tod Schulthess in Alpine, Utah.

How much funding has Thunder Biotech raised?

Thunder Biotech has raised $19.4M across 3 rounds on record. The most recent is an undisclosed round of $100k announced in Feb 2024.

When did Thunder Biotech last raise funding?

Thunder Biotech's most recent funding round on record is an undisclosed round of $100k, announced in Feb 2024.

Who founded Thunder Biotech?

FundedIQ lists Jeff Hone (Founder) at Thunder Biotech.

Who is the CEO of Thunder Biotech?

Tod Schulthess is listed as CEO at Thunder Biotech.

Where is Thunder Biotech headquartered?

Thunder Biotech is based in Provo, Utah, United States.

How many employees does Thunder Biotech have?

Thunder Biotech is in the 11-50 employee band.

How does Thunder Biotech's funding compare to other Biotechnology startups?

Thunder Biotech's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Thunder Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Thunder Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.